Cas 917889-31-7,3-(4-fluoro-benzyl)-2,4-dioxo-1,2,3,4-tetrahydro-quinazoline-7-carboxylic acid methyl ester

917889-31-7

Post Buying Request

Basic information

Product Name: 3-(4-fluoro-benzyl)-2,4-dioxo-1,2,3,4-tetrahydro-quinazoline-7-carboxylic acid methyl ester
Synonyms: 3-(4-fluoro-benzyl)-2,4-dioxo-1,2,3,4-tetrahydro-quinazoline-7-carboxylic acid methyl ester
CAS NO:917889-31-7
Molecular Formula:
Molecular Weight: 328.3
EINECS: N/A
Product Categories: N/A
Mol File: 917889-31-7.mol
Article Data: 2

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 3-(4-fluoro-benzyl)-2,4-dioxo-1,2,3,4-tetrahydro-quinazoline-7-carboxylic acid methyl ester(CAS DataBase Reference)
NIST Chemistry Reference: 3-(4-fluoro-benzyl)-2,4-dioxo-1,2,3,4-tetrahydro-quinazoline-7-carboxylic acid methyl ester(917889-31-7)
EPA Substance Registry System: 3-(4-fluoro-benzyl)-2,4-dioxo-1,2,3,4-tetrahydro-quinazoline-7-carboxylic acid methyl ester(917889-31-7)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 917889-31-7(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

917889-31-7 Suppliers

Recommended suppliersmore

917889-31-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 917889-31-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,7,8,8 and 9 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 917889-31:
(8*9)+(7*1)+(6*7)+(5*8)+(4*8)+(3*9)+(2*3)+(1*1)=227
227 % 10 = 7
So 917889-31-7 is a valid CAS Registry Number.

917889-31-7Upstream product

917889-31-7Downstream Products

917889-31-7Relevant articles and documents

PHARMACEUTICAL COMPOSITIONS CONTAINING QUINAZOLINE DERIVATIVES FOR TREATING AS SEROTONIN RECEPTOR ANTAGONIST

-

, (2009/07/02)

The present invention relates to a pharmaceutical composition containing one or more quinazoline compounds as an active ingredient, which has antagonistic activity against serotonin 5-HT3A and is effective for the prevention and treatment of ce

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 917889-31-7